Wassil Jim
Wassil Jim, EVP, CSO, COO, reported a transaction classified as withholding at Vaxcyte, Inc. involving 5459.000000 shares for an estimated $329505.24. Reported holdings after the transaction were 146769.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PCVX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001813798-26-000019 Common Stock
- Transaction date
- Sep 08, 2026 Filed Sep 09, 2026, 09:46 PM · 1d delay
- Shares
- 5,459 sh $60.36 per share
- Estimated value
- -$329k Computed from shares × price
- Holdings after
- 146,769 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-22 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, Chief Scientific Ofc, COO
- F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
- F2
The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder o…
issuer, full information regarding the number of shares sold at each separate price.
- F3
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F4
The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder…
0 other transactions
0 recent txs